Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 205 K | $16.8 M | $81.91 | Jan 31, 2022 | Direct |
Scholar Rock Holding Corp | CHIEF MEDICAL OFFICER | Common Stock | 72.9 K | $1.16 M | $15.93 | Feb 12, 2024 | Direct |
Arcturus Therapeutics Holdings Inc. | Director | Common Stock | 3.13 K | $100 K | $32.03 | Jun 14, 2024 | Direct |
Arcturus Therapeutics Holdings Inc. | Director | Deferred Stock Units | 0 | $0 | $32.03 | Jun 14, 2024 | Direct |
Scholar Rock Holding Corp | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 97.1 K | Feb 12, 2024 | Direct | ||
Arcturus Therapeutics Holdings Inc. | Director | Stock option (right to buy) | 15 K | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc. | Jun 14, 2024 | 3 | $0 | 4 | Jun 18, 2024 | Director |
SRRK | Scholar Rock Holding Corp | Feb 12, 2024 | 2 | $0 | 4 | Feb 13, 2024 | CHIEF MEDICAL OFFICER |
ARCT | Arcturus Therapeutics Holdings Inc. | Aug 1, 2023 | 2 | $0 | 4 | Aug 3, 2023 | Director |
SRRK | Scholar Rock Holding Corp | Nov 14, 2022 | 1 | $0 | 4 | Nov 15, 2022 | Chief Medical Officer |
SRRK | Scholar Rock Holding Corp | Nov 9, 2022 | 0 | $0 | 3 | Nov 15, 2022 | Chief Medical Officer |
ARCT | Arcturus Therapeutics Holdings Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
KRYS | Krystal Biotech, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Chief Business Officer |
ARCT | Arcturus Therapeutics Holdings Inc. | Dec 7, 2021 | 2 | $0 | 4 | Dec 9, 2021 | Director |
ARCT | Arcturus Therapeutics Holdings Inc. | Dec 7, 2021 | 0 | $0 | 3 | Dec 9, 2021 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |